{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:28:26Z","timestamp":1762522106181},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9326-17","type":"journal-article","created":{"date-parts":[[2017,11,19]],"date-time":"2017-11-19T22:03:23Z","timestamp":1511129003000},"page":"741-744","source":"Crossref","is-referenced-by-count":9,"title":["Thrombotic Microangiopathy Presenting with Intestinal Involvement Following Long-term Interferon-\u03b21b Treatment for Multiple Sclerosis"],"prefix":"10.2169","volume":"57","author":[{"given":"Shusaku","family":"Omoto","sequence":"first","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Utsumi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Matsuno","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Terasawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med 371: 654-666, 2014.","DOI":"10.1056\/NEJMra1312353"},{"key":"2","unstructured":"2. Vosoughi R, Marriott JJ. Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: review of literature and report of two new cases. Mult Scler Relat Disord 3: 321-325, 2014."},{"key":"3","unstructured":"3. Nishio H, Tsukamoto T, Matsubara T, Okada Y, Takahashi R, Yanagita M. Thrombotic microangiopathy caused by interferon beta-1b for multiple sclerosis: a case report. CEN Case Rep 5: 179-183, 2016."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129-1136, 2008.","DOI":"10.1056\/NEJMoa0707330"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Goldberg RJ, Nakagawa T, Johnson RJ, Thurman JM. The role of endothelial cell injury in thrombotic microangiopathy. Am J Kidney Dis 56: 1168-1174, 2010.","DOI":"10.1053\/j.ajkd.2010.06.006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kumpfel T, Then Bergh F, Pollmacher T, Holsboer F, Trenkwalder C. Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS. Neurology 55: 1231-1233, 2000.","DOI":"10.1212\/WNL.55.8.1231"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takano S, Ishikawa E, Matsuda M, Yamamoto T, Matsumura A. Interferon-beta inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10. Int J Oncol 45: 1837-1846, 2014.","DOI":"10.3892\/ijo.2014.2620"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zheng H, Qian J, Carbone CJ, Leu NA, Baker DP, Fuchs SY. Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis. Blood 118: 4003-4006, 2011.","DOI":"10.1182\/blood-2011-06-359745"},{"key":"9","unstructured":"9. Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 19: 415-417, 1998."},{"key":"10","unstructured":"10. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 23: 1038-1048, 2002."},{"key":"11","unstructured":"11. Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher 31: 149-162, 2016."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kavanagh D, McGlasson S, Jury A, et al. Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature. Blood 128: 2824-2833, 2016.","DOI":"10.1182\/blood-2016-05-715987"},{"key":"13","unstructured":"13. Kundra A, Wang JC. Interferon induced thrombotic microangiopathy (TMA): analysis and concise review. Crit Rev Oncol Hematol 112: 103-112, 2017."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. El-Bietar J, Warren M, Dandoy C, et al. Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 21: 1994-2001, 2015.","DOI":"10.1016\/j.bbmt.2015.06.016"},{"key":"15","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.1981.03320170043028","volume":"246","author":"DR Harkness","year":"1981","unstructured":"15. Harkness DR, Byrnes JJ, Lian EC, Williams WD, Hensley GT. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA 246: 1931-1933, 1981.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/5\/57_9326-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T09:42:49Z","timestamp":1570354969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/5\/57_9326-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9326-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}